1. Viswanatha DS, Dogan A. Hepatitis C virus and lymphoma. J Clin Pathol. 2007; 60:1378–1383.
2. Amin J, Dore GJ, O'Connell DL, Bartlett M, Tracey E, Kaldor JM, et al. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J Hepatol. 2006; 45:197–203.
3. Suriawinata A, Thung SN. Hepatitis C virus and malignancy. Hepatol Res. 2007; 37:397–401.
4. De Vita S, Zagonel V, Russo A, Rupolo M, Cannizzaro R, Chiara G, et al. Hepatitis C virus, non-Hodgkin's lymphomas and hepatocellular carcinoma. Br J Cancer. 1998; 77:2032–2035.
5. Mazzaro C, Tirelli U, Pozzato G. Hepatitis C virus and non-Hodgkin's lymphoma 10 years later. Dig Liver Dis. 2005; 37:219–226.
6. Libra M, Gasparotto D, Gloghini A, Navolanic PM, De Re V, Carbone A. Hepatitis C virus (HCV) I hepatitis C virus (HCV) infection and lymphoproliferative disorders. Front Biosci. 2005; 10:2460–2471.
7. Weng WK, Levy S. Hepatitis C virus (HCV) and lymphomagenesis. Leuk Lymphoma. 2003; 44:1113–1120.
8. Carter RH, Fearon DT. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science. 1992; 256:105–107.
9. Petracca R, Falugi F, Galli G, Norais N, Rosa D, Campagnoli S, et al. Structure-function analysis of hepatitis C virus envelope-CD81 binding. J Virol. 2000; 74:4824–4830.
10. Heidecke S, Stippel DL, Hoelscher AH, Wedemeyer I, Dienes HP, Drebber U. Simultaneous occurrence of a hepatocellular carcinoma and a hepatic non-Hodgkin's lymphoma infiltration. World J Hepatol. 2010; 2:246–250.